These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30471240)

  • 1. Quantitative Urinary Proteome Reveals Potential Biomarkers for Ureteropelvic Junction Obstruction.
    Chen H; Lin H; Xu M; Xu G; Fang X; He L; Chen Z; Wu Z; Geng H
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800101. PubMed ID: 30471240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach.
    Mesrobian HG; Mitchell ME; See WA; Halligan BD; Carlson BE; Greene AS; Wakim BT
    J Urol; 2010 Aug; 184(2):709-14. PubMed ID: 20639044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction.
    Yu L; Zhou L; Li Q; Li S; Luo X; Zhang C; Wu B; Brooks JD; Sun H
    J Pediatr Urol; 2019 Feb; 15(1):44.e1-44.e7. PubMed ID: 30420258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Proteome of Infant Stenotic Ureters Reveals Extracellular Matrix Organization and Oxidative Stress Dysregulation Underlying Ureteropelvic Junction Obstruction.
    Li Y; Chen Z; Zhang J; Zhang Q; He L; Xu M; Xu G; Geng H; Fang X
    Proteomics Clin Appl; 2020 Nov; 14(6):e2000030. PubMed ID: 32969194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
    Gerber C; Harel M; Lynch ML; Herbst KW; Ferrer FA; Shapiro LH
    J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary proteome analysis in patients with stable SFU grade 4 ureteropelvic junction obstruction differs from normal.
    Mesrobian HG; Kryger JV; Groth TW; Fiscus GE; Mirza SP
    Urology; 2013 Sep; 82(3):745.e1-10. PubMed ID: 23987180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary biomarkers in hydronephrosis.
    Madsen MG
    Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between NDUFS1 from urinary extracellular vesicles and decreased differential renal function in children with ureteropelvic junction obstruction.
    Bu L; Zhang L; Wang X; Du G; Wu R; Liu W
    BMC Nephrol; 2024 May; 25(1):158. PubMed ID: 38720274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary polyomavirus: novel biomarker of congenital ureteropelvic junction obstruction.
    Assadi F; Mazaheri M
    J Pediatr Urol; 2020 Feb; 16(1):107.e1-107.e5. PubMed ID: 31818677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary carbohydrate antigen 19-9/creatinine ratio: A non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children.
    Alizadeh F; Taefnia AM; Haghdani S
    J Pediatr Urol; 2018 Feb; 14(1):62.e1-62.e4. PubMed ID: 29079483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy.
    Gupta S; Jackson AR; DaJusta DG; McLeod DJ; Alpert SA; Jayanthi VR; McHugh K; Schwaderer AR; Becknell B; Ching CB
    J Pediatr Urol; 2018 Jun; 14(3):238.e1-238.e6. PubMed ID: 29706289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction.
    Palmer LS; Maizels M; Kaplan WE; Firlit CF; Cheng EY
    Urology; 1997 Nov; 50(5):769-73. PubMed ID: 9372890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary proteome analysis identifies infants but not older children requiring pyeloplasty.
    Drube J; Zürbig P; Schiffer E; Lau E; Ure B; Glüer S; Kirschstein M; Pape L; Decramer S; Bascands JL; Schanstra JP; Mischak H; Ehrich JH
    Pediatr Nephrol; 2010 Sep; 25(9):1673-8. PubMed ID: 20180135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy.
    Decramer S; Zürbig P; Wittke S; Mischak H; Bascands JL; Schanstra JP
    Contrib Nephrol; 2008; 160():127-141. PubMed ID: 18401166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel urinary biomarker protein panel to identify children with ureteropelvic junction obstruction - A pilot study.
    Devarakonda CKV; Shearier ER; Hu C; Grady J; Balsbaugh JL; Makari JH; Ferrer FA; Shapiro LH
    J Pediatr Urol; 2020 Aug; 16(4):466.e1-466.e9. PubMed ID: 32620509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary proteome analysis and the management of ureteropelvic junction obstruction.
    Mesrobian HG
    Pediatr Nephrol; 2010 Sep; 25(9):1595-6. PubMed ID: 20407913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.
    Grandaliano G; Gesualdo L; Bartoli F; Ranieri E; Monno R; Leggio A; Paradies G; Caldarulo E; Infante B; Schena FP
    Kidney Int; 2000 Jul; 58(1):182-92. PubMed ID: 10886563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Proteomics Yield Pathological Insights for Ureteropelvic Junction Obstruction.
    Froehlich JW; Kostel SA; Cho PS; Briscoe AC; Steen H; Vaezzadeh AR; Lee RS
    Mol Cell Proteomics; 2016 Aug; 15(8):2607-15. PubMed ID: 27215552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of newborn urinary proteome analysis in the evaluation and management of ureteropelvic junction obstruction: a cost-effectiveness study.
    Mesrobian HG
    World J Urol; 2009 Jun; 27(3):379-83. PubMed ID: 19034461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary and serum biomarkers in ureteropelvic junction obstruction: a systematic review.
    Papachristou F; Pavlaki A; Printza N
    Biomarkers; 2014 Nov; 19(7):531-40. PubMed ID: 25082300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.